Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092022 · ClinicalTrials.gov registry record · NA
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
A NA study of Cervical Cancer Screening, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05092022: Recruiting NA study of Cervical Cancer Screening, sponsored by Milton S. Hershey Medical Center.
NCT05092022 is a NA study of Cervical Cancer Screening that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants, below the 323-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05092022, a NA study of Cervical Cancer Screening, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
Primary Outcome
This outcome is measuring the number of patients who select to receive a self-sampled HPV test out of all patients presented with the research opportunity. The results will be presented as the acceptance rate of the self-sampled HPV test. The measurement tool for this outcome is a patient-completed questionnaire where the patient can request 1) a self-sampled HPV test, 2) a clinician-sampled test, or 3) to not receive their cervical cancer screening at this time.
Conditions Studied
Interventions
- DEVICE Evalyn Self-Sampling Brush
Study Locations (1)
Pennsylvania
- Penn State Health St. Joseph's - Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05092022 shows while recruiting
NCT05092022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 323-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Cervical Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Evalyn Self-Sampling Brush is the first listed.
NCT05092022 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05092022 about?
NCT05092022 is a clinical study titled "St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic". This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV t...
What is the current status of trial NCT05092022?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-18. Estimated completion is 2026-12-31.
What conditions does trial NCT05092022 study?
This clinical trial studies the following conditions: Cervical Cancer Screening.
What interventions are being tested in trial NCT05092022?
The interventions under investigation include: Evalyn Self-Sampling Brush (DEVICE).
Who is sponsoring clinical trial NCT05092022?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05092022 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection
RECRUITING · NA
-
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
ACTIVE NOT RECRUITING · NA
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
-
Emergency Room HPV Self-Sampling Study (ACT NOW)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI